Kuehn Law Investigates Globus Medical Directors for Potential Breach of Fiduciary Duty
Shareholder litigation firm Kuehn Law is investigating certain officers and directors of Globus Medical, Inc. (NYSE: GMED) for alleged breaches of fiduciary duties, including potential self-dealing.
Kuehn Law, PLLC, a law firm specializing in shareholder litigation, has launched an investigation into the conduct of certain officers and directors at Globus Medical, Inc. (NYSE: GMED). The firm is examining allegations that company leadership may have breached their fiduciary duties to shareholders, specifically concerning potential instances of self-dealing.
The investigation aims to determine if any corporate actions taken by these individuals constituted self-enrichment or conflicted with their obligations to the company and its investors. Kuehn Law is seeking information from current and former shareholders who may possess relevant details regarding these matters.
Globus Medical, Inc. is a company involved in the development and marketing of spinal and orthopedic implants and instrumentation. The company's stock is publicly traded on the New York Stock Exchange under the ticker symbol GMED.
Shareholders with concerns or information are encouraged to contact Kuehn Law for further details regarding the investigation.